BioNTech SE (BNTX) Total Debt (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Debt data on file, last reported at $409.4 million in Q4 2025.

• For the quarter ending Q4 2025, Total Debt fell 86.73% year-over-year to $409.4 million; the trailing twelve-month figure through Dec 2025 stood at $409.4 million (down 86.73% YoY), and the FY2025 full-year result was $397.4 million, down 87.12% from the prior year.
• Total Debt eased to $409.4 million in Q4 2025, from $698.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $3.1 billion in Q4 2024 to a low of $157.2 million in Q2 2024.
• A 5-year average of $861.7 million and a median of $487.2 million in 2023 frame the typical range for Total Debt.
• Across the five-year window, Total Debt surged 739.88% in 2021 and plunged 86.73% in 2025, its largest moves.
• Tracing BNTX's Total Debt over 5 years: stood at $3.1 billion in 2021, then sank by 47.57% to $1.6 billion in 2022, then sank by 44.23% to $893.5 million in 2023, then surged by 245.27% to $3.1 billion in 2024, then sank by 86.73% to $409.4 million in 2025.
• Business Quant data shows BNTX's Total Debt at $409.4 million in Q4 2025, $698.4 million in Q3 2025, and $164.1 million in Q2 2025.